Suppr超能文献

医用大麻的伦理问题:政府限制与医疗必要性

The ethics of medical marijuana: government restrictions vs. medical necessity.

作者信息

Clark P A

机构信息

Saint Joseph's Philadelphia's Jesuit University, Pennsylvania 19131-1395, USA.

出版信息

J Public Health Policy. 2000;21(1):40-60.

Abstract

Marijuana is listed by the Drug Enforcement Agency (DEA) as an illegal Schedule I drug which has no currently accepted medical use. However, on March 17, 1999, 11 independent scientists appointed by the Institute of Medicine reported that medical marijuana was effective in controlling some forms of pain, alleviating nausea and vomiting due to chemotherapy, treating wasting due to AIDS, and combating muscle spasms associated with multiple sclerosis. There was also no evidence that using marijuana would increase illicit drug use or that it was a "gateway" drug. Despite this evidence the DEA refuses to reclassify marijuana as a Schedule II drug, which would allow physicians to prescribe unadulterated and standardized forms of marijuana. After reviewing the pertinent scientific data and applying the principle of double effect, there is a proportionate reason for allowing physicians to prescribe marijuana. Seriously ill patients have the right to effective therapies. To deny patients access to such a therapy is to deny them dignity and respect as persons.

摘要

美国药品管理局(DEA)将大麻列为非法的第一类药物,目前没有被认可的医疗用途。然而,1999年3月17日,由医学研究所任命的11位独立科学家报告称,医用大麻在控制某些形式的疼痛、缓解化疗引起的恶心和呕吐、治疗艾滋病导致的消瘦以及对抗与多发性硬化症相关的肌肉痉挛方面有效。也没有证据表明使用大麻会增加非法药物的使用,或者它是一种“入门”毒品。尽管有这些证据,DEA仍拒绝将大麻重新分类为第二类药物,而这将允许医生开处方未掺假和标准化形式的大麻。在审查了相关科学数据并应用双重效应原则后,有合理的理由允许医生开大麻处方。重症患者有权获得有效的治疗方法。拒绝患者获得这种治疗方法就是剥夺他们作为人的尊严和尊重。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验